Zhao J, Xu B, Xie S, Zhang Q, Li Y P
Department of Reproductive Medicine, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha City, Hunan Province, 410008, People's Republic of China.
Reprod Biol Endocrinol. 2016 Sep 22;14(1):62. doi: 10.1186/s12958-016-0197-2.
Previous studies have explored the effect of granulocyte colony stimulating factor (G-CSF) administration on the outcome of assisted reproductive technology (ART), and came into controversial conclusions. The present meta-analysis aims to assess whether G-CSF administration has beneficial effect on the outcome after ART.
The electronic databases Pubmed, Embase and Google Scholar were searched up to May 2016. Articles that studied the effect of G-CSF administration on the outcome after ART were included in the present meta-analysis. Odds ratio (OR) with 95 % confidence interval (95 % CI) were calculated to assess the effect of G-CSF administration on the outcome after ART. The outcomes of interest were implantation rate (IR) and pregnancy rate (PR).
Four cohort studies with 1101 embryos transplantation assessed the effect of G-CSF administration on IR and 6 studies with 621 cycles assessed the role of G-CSF administration in PR. Meta-analysis did not found an increased embryo IR in G-CSF administration cycles [OR 1.59 (95 % CI 0.74-3.41). whereas the PR with G-CSF administration was significantly higher compared with cases without G-CSF administration [OR 2.03 (95 % CI 1.19-3.46)]. Additionally, we found that G-CSF administrated subcutaneously resulted in significantly higher PR [OR 3.12 (95 % CI 1.67-5.81)] and IR [OR 2.82 (95 % CI 1.29-6.15)] compared with control group, whereas G-CSF administrated via local uterine infusion had no beneficial effect on the PR [OR 1.42 (95 % CI 0.91-2.24)] and IR [OR 1.10 (95 % CI 0.76-1.60)] after ART.
G-CSF administration may have beneficial effect on clinical pregnancy outcome after ART. Subcutaneous injection may be an optimal route of G-CSF administration. Further cohort studies are required to explore the mechanisms undergone the effect and investigate the best route and dose of G-CSF administration.
既往研究探讨了粒细胞集落刺激因子(G-CSF)给药对辅助生殖技术(ART)结局的影响,但得出了相互矛盾的结论。本荟萃分析旨在评估G-CSF给药对ART后结局是否具有有益作用。
检索截至2016年5月的电子数据库PubMed、Embase和谷歌学术。本荟萃分析纳入了研究G-CSF给药对ART后结局影响的文章。计算比值比(OR)及其95%置信区间(95%CI),以评估G-CSF给药对ART后结局的影响。感兴趣的结局指标为着床率(IR)和妊娠率(PR)。
四项涉及1101例胚胎移植的队列研究评估了G-CSF给药对IR的影响,六项涉及621个周期的研究评估了G-CSF给药在PR中的作用。荟萃分析未发现G-CSF给药周期的胚胎IR增加[OR 1.59(95%CI 0.74 - 3.41)],而与未给予G-CSF的病例相比,给予G-CSF的PR显著更高[OR 2.03(95%CI 1.19 - 3.46)]。此外,我们发现与对照组相比,皮下注射G-CSF导致PR[OR 3.12(95%CI 1.67 - 5.81)]和IR[OR 2.82(95%CI 1.29 - 6.15)]显著更高,而ART后经局部子宫灌注给予G-CSF对PR[OR 1.42(95%CI 0.91 - 2.24)]和IR[OR 1.10(95%CI 0.76 - 1.60)]没有有益作用。
G-CSF给药可能对ART后的临床妊娠结局具有有益作用。皮下注射可能是G-CSF给药的最佳途径。需要进一步的队列研究来探讨其作用机制,并研究G-CSF给药的最佳途径和剂量。